MedCap AB is a Swedish investment company specializing in the acquisition and development of profitable, market-leading niche companies within the life science industry, particularly in Northern Europ... MedCap AB is a Swedish investment company specializing in the acquisition and development of profitable, market-leading niche companies within the life science industry, particularly in Northern Europe. Founded in 2001 and headquartered in Stockholm, it operates across three primary business areas: Assistive Tech, MedTech, and Specialty Pharma, focusing on biotechnology, medical technology, healthcare equipment, pharmaceuticals, and assistive technologies. The company's diverse portfolio includes subsidiaries such as Abilia, which provides assistive technology for cognition, communication, and environmental control; Inpac, offering contract manufacturing and pharmaceutical packaging; Unimedic, specializing in specialty pharmaceuticals and CDMO services; Multi-ply, producing carbon fiber components for medtech; and others like Trident, Huka, Erimed, SurgiCube, Toul Meditech, and Danrehab, serving markets from Nordic regions to global exports. As an active, long-term owner, MedCap provides capital, expertise, networks, and strategic support through independent subsidiaries, fostering international growth, profitability, and sustainability in the healthcare and life sciences sectors.
We have not yet reviewed MedCap's disclosures for Waste Management data.
If this data is relevant to your work, you can submit a data coverage request and our team
will investigate the company's disclosures and capture the data if available.